title: Vistogard (Uridine Triacetate): The First and Only Drug Approved for the Treatment of 5-Fluorouracil or Capecitabine Overdose: Implications for the Clinical Nurse Specialist.
authors.affiliation: Author Affiliation: Nurse Researcher, Center for Nursing Excellence, Premier Health-Miami Valley Hospital, Dayton, Ohio.
authors.forename: Patricia Anne
authors.initials: PA
authors.lastname: O'Malley
mesh_terms: D000085:Acetates / Q000627:therapeutic use*; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use / Q000633:toxicity; D000069287:Capecitabine / Q000627:therapeutic use / Q000633:toxicity*; D017277:Drug Approval; D062787:Drug Overdose / Q000188:drug therapy* / Q000451:nursing; D005472:Fluorouracil / Q000627:therapeutic use / Q000633:toxicity*; D006801:Humans; D009720:Nurse Clinicians; D014481:United States; D014486:United States Food and Drug Administration; D014529:Uridine / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000085:Acetates; D000964:Antimetabolites, Antineoplastic; C000609666:uridine triacetate; D000069287:Capecitabine; D005472:Fluorouracil; D014529:Uridine